Biotech IMP761 Late-Breaking Abstract at ACR Convergence 2026 Highlights Statistically Significant & Exposure-Dependent Inhibition of T-Cell-Driven Immune Responses November 9, 2026
Biotech Mineralys Therapeutics Presents New Late-Breaking Data from Transform-HTN Open-Label Extension Trial of Lorundrostat in Hypertension at AHA Scientific Sessions 2026 November 9, 2026
Biotech argenx to Acquire Unnatural Products, Inc., Adding Peptide Discovery Engine to Broaden Immunology Capabilities November 9, 2026
Biotech ACR 2026: Dapirolizumab Pegol Associated with Greater Treatment Response Rates Versus Placebo in SLE Using Novel Treatment Response Measure November 9, 2026
Biotech argenx Presents Phase 3 ALKIVIA Data at ACR Convergence 2026 Showing Rapid and Sustained Improvement with Efgartigimod in Autoimmune Myositis November 8, 2026
Biotech Biofrontera Inc. to Report Third Quarter 2026 Financial Results on November 13, 2026 November 7, 2026
Biotech MHRA approves Pharming’s Joenja® (leniolisib) as first treatment specifically for children with APDS in the U.K. November 6, 2026
Biotech Rakovina Therapeutics to Present Brain-Penetrant ATR Inhibitor Data at the 31st Society for Neuro-Oncology Annual Meeting November 5, 2026
Biotech Vivoryon Therapeutics N.V. Reports Q3 2026 Financial Results and Provides Business Update November 5, 2026
Search
Biotech
November 9, 2026
November 9, 2026
November 9, 2026
November 9, 2026
November 8, 2026
November 7, 2026
November 6, 2026
November 6, 2026
November 5, 2026
November 5, 2026
